This article has been retracted: Aging has completed its investigation of this paper. We found multiple external duplications of the panels showing colony formation assays in Figure 5C. The authors reused previously published data from colony formation assay published in a different study [1] and again used some of the images in a later published article [2]. In addition, there are duplications of plate images from papers from unrelated labs [3, 4]. The corresponding author asked to withdraw/retract this paper and mentioned that: “the first author mislabeled the samples and I lost the confidence in the reliability of the conclusion.” No responses were received from the other authors. Because the validity of the reported results and conclusions is under the question, the Aging Editors retracted this article.
References
- 1. Sun CC, Li SJ, Li DJ. Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Oncotarget. 2016; 7:35960–78. https://doi.org/10.18632/oncotarget.8482 [PubMed]
- 2. Sun CC, Li SJ, Zhang F, Zhang YD, Zuo ZY, Xi YY, Wang L, Li DJ. The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression. Mol Ther Nucleic Acids. 2016; 5:e387. https://doi.org/10.1038/mtna.2016.96 [PubMed]
- 3. Chen G, Hu J, Huang Z, Yang L, Chen M. MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. Biochem Biophys Res Commun. 2016; 473:1144–51. https://doi.org/10.1016/j.bbrc.2016.04.030 [PubMed]
- 4. Zhang T, Cai X, Li Q, Xue P, Chen Z, Dong X, Xue Y. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC). Oncotarget. 2016; 7:42225–40. https://doi.org/10.18632/oncotarget.9944 [PubMed]